Medtronic recalls MiniMed insulin infusion sets
FDA sent out a MedWatch warning, on July 12, 2013, after Medtronic recalled its MiniMed Paradigm insulin infusion sets.
FDA sent out a MedWatch warning, on July 12, 2013, after Medtronic recalled its MiniMed Paradigm insulin infusion sets.
Medtronic sent an Urgent Medicinal Device Safety Notification to all Paradigm insulin pump users and distributors to alert them that certain lots have the potential for over or under delivery of insulin. “If insulin or other fluids come in contact with the inside of the tubing connector, this can result in too much or too little insulin being delivered, resulting in hypoglycemia or hyperglycemia, which can be severe and lead to serious illness,” the MedWatch warning said.
The recalled products were manufactured from October 2001 through June 2013 and distributed from December 2001 through June 2013.
If patients notice anything unusual during the infusion set prime process, such as the insulin continuing to drip from the tip of the infusion set cannula when priming has been completed, this may indicate that the connector vents are not working properly, according to FDA. “If this occurs, do not insert the infusion set and immediately call the HelpLine at 1-888-204-7616 for assistance,” FDA stated.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
